the American Academy of Orofacial Pain, the group of conditions comprising TMD was included in this medical, diagnostic classification. Many disease entities in the oral and facial region, including TMD, present with similar pain patterns. Since the majority of these are medical conditions, dentists must consider diseases unrelated to the masticatory system and include them in their differential diagnosis. As well as this, it is difficult to correctly diagnose orofacial pain, particularly because of the complex interrelationship of somatic (Axis I) and psychosocial (Axis II) factors in the aetiology of these and general chronic pain disorders. As well as somatic factors, psychosocial factors, eg, anxiety, depression and stress, considerably contribute to the patient's pain(s). Okeson consequently states that a treatment plan, based on the correct diagnosis, must include collaboration with a mental health professional. 3, 4 For the treatment of TMD, many modalities have been proposed. Given the level of evidence of literature summarised in this review, TCA would not be the first choice with which to start treatment in people with a TM diagnosis: When, after a comprehensive interdisciplinary, somatic examination, a specific TM-diagnosis is in doubt, a mental health professional must be consulted along with other disciplines when making the definitive treatment plan. An interdisciplinary team may, however, conclude that TCA are a fair treatment option for a specific TM-diagnosis. Therefore the relevance of this systematic review for the general practitioner is that they should refer to an orofacial pain specialist or similar oriented clinic, when a more complex disorder is suspected.
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Abstracted from
Cascos-Romero J, Vázquez-Delgado E, Vázquez-Rodríguez E, Gay-Escoda C. Data extraction and synthesis A qualitative review was conducted.
Results 11 articles were identified, seven of which were reviews.
Conclusions There is evidence, based on inconsistent or limited-quality patient-oriented data (SORT level B recommendation), for the use of tricyclic antidepressants (TCA) in the treatment of temporomandibular joint disorders (TMD). 
